The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling ...

This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...

Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have ...

The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

Idaho’s population is becoming increasingly sicker with multiple, chronic conditions, and sadly our state ranks last in the nation in access to primary care physicians. | Opinion ...

Inflation is the tendency for prices of goods ... like medical care paid for by employer-provided insurance or Medicare and Medicaid. CPI doesn’t keep up with these in-direct expenses.

Its flawed income measure leads to the overpayment of welfare, including Medicaid, to recipients.

Julie Patterson, Pharm.D., Ph.D., of the National Pharmaceutical Council, tells Managed Healthcare Executive at the annual ...

For retirees, one of the biggest financial fears isn’t just rising prices — it’s running out of money too soon. Inflation ...

America’s senior population is the largest it has ever been and is predicted to nearly double by 2050. To meet the needs of ...